Pathology testing is the study of the mechanism of disease occurrence and development, through the study of disease histology, cytology and biochemistry, can reveal the mechanism of disease occurrence, development and regression. In the process of drug development, pathology is of great significance in evaluating the effectiveness and safety of drugs. Animal clinical testing is a comprehensive assessment of clinical hematology and biochemistry in experimental animals to understand the efficacy or toxicity of a drug in animals. Pathology and animal clinical testing provide important efficacy and safety assessment data for the drug development process, which helps to clarify the efficacy and toxicity characteristics of the drug as well as the safe dose range, and guides the design and implementation of preclinical and clinical trials.

CIR Biopharma has extensive experience in sampling and sample preparation for pathology analysis, pathology staining (routine staining plus assay development), toxicology diagnosis and pathology reporting, immunohistochemistry/immunofluorescence staining, and clinical testing and analysis. The pathology and clinical testing team has many years of experience in drug safety evaluation, focusing on toxicology evaluation of drugs in Non-GLP/GLP environment.